Search
for
Sort by
Research 61–90 of 1000+
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil
- Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Recommendations on trichological treatments during COVID-19 pandemic
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
- Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia
- Androgen sensitivity gateway to COVID‐19 disease severity
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Dermatologic Changes in Experimental Model of Long COVID
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin